DOTmed Home MRI Oncology Ultrasound Molecular Imaging X-Ray Cardiology Health IT Business Affairs
News Home Parts & Service Operating Room CT Women's Health Proton Therapy Endoscopy HTMs Mobile Imaging
SEARCH
Ubicación actual:
>
> This Story


Conexión o Registro to rate this News Story
Forward Printable StoryPrint Comment

 

 

Business Affairs Homepage

Brainlab to become distributor of Elekta's stereotactic neurosurgery products in US Already the supplier in select European markets

Hitachi acquires Mitsubishi Electric’s particle therapy system business Will integrate with Hitachi's own particle therapy division to form one entity

3-D printed middle-ear to correct hearing loss shows promise at RSNA Further evidence of CT and 3-D printing synergy

Q&A with David Pacitti, President of Siemens Medical Solutions USA, Inc. and Head of Siemens Healthineers North America Insights from the show floor at RSNA

Philips acquires VitalHealth for an undisclosed amount Adds to its population health management portfolio

Edwards acquires Harpoon Medical Company now owns the image-guiding HARPOON System

Dignity Health, Catholic Health Initiatives agree to merge into giant, new Catholic health system Will provide care in 28 states

Image Diagnostics monitor to be enhanced with new video management system Add-on to the first large field 4k mobile and multi-modality monitor

Frans van Houten, CEO of Philips, on the future of radiology Discussing the demands for relevant innovations and the arrival of 'clinical data scientists'

Cerveau signs research contract with UV Medical Center in Amsterdam For the manufacture and supply of PET agent MK-6240

Boston Scientific has agreed to acquire
Apama Medical for $300 million

Boston Scientific to acquire Apama Medical

por John Fischer , Staff Reporter
Boston Scientific Corporation has agreed to acquire Apama Medical Inc. for a sum of $300 million.

The acquisition of the privately-held, California-based company will allow Boston Scientific to expand its electrophysiology portfolio, combining its radiofrequency point-by-point solution with Apama’s single-shot balloon ablation technology for the treatment of atrial fibrillation (AF).

Story Continues Below Advertisement

Putting Your Enterprise Imaging Strategy in Place:

8 Tips for Selecting the Right Transformation Partner. As the healthcare industry moves toward a more personalized, value-based care model, choosing the right solution partner to obtain a truly transformational enterprise imaging strategy is paramount.



“Single-shot pulmonary vein isolation (PVI) ablation is a high growth market segment,” Joe Fitzgerald, president of rhythm management at Boston Scientific, told HCB News. “Our current electrophysiology (EP) portfolio includes a radiofrequency (RF) point-by-point solution, and the Apama technology, upon regulatory approval, will allow us to expand into the single-shot market segment, and ultimately bolster our entire EP portfolio.”

PVI is the current standard form of treatment in AF ablations and is performed using either point-by-point RF-based ablation or single-shot balloon-based ablation.

As part of the agreement, Boston Scientific will acquire Apama’s concept device, the Apama Radiofrequency (RF) Balloon Catheter System, which combines the primary benefits of RF point-by-point and balloon-based ablation approaches, allowing physicians to administer different amounts of energy and shorten procedure times.

Boston Scientific plans to integrate the RF balloon system with its RHYTHMIA HDx Mapping System, the only high density and high resolution map in the industry, to provide physicians with never before seen visualization of the heart during ablation procedures. It also will acquire intellectual property and 40 employees from Apama.

“The Apama RF Balloon System offers benefits to both patients and physicians as its initial clinical results have demonstrated that the technology meets the study endpoints of safety and efficacy, while also offering improvements to procedure efficiency,” Amr Salahieh, the CEO and president of Apama Medical, told HCB News.

The RHYTHMIA HDx Mapping System is available to consumers. The Apama RF Balloon Catheter System is still being studied and is not yet for sale.

An upfront cash transaction of $175 million has already been paid. A maximum of $125 million in contingent payments will be made between 2018 and 2020 based on successes in clinical and regulatory processes.

Completion of the acquisition is expected in the fourth quarter of 2017, subject to customary closing conditions.

Business Affairs Homepage


You Must Be Logged In To Post A Comment

Anuncie
Aumente su conciencia de marca
Subastas + ventas Privadas
Consigue el mejor precio
Comprar Equipo/Piezas
Encuentra El Precio Más Bajo
Noticias diarias
Lee las últimas noticias
Directorio
Examina todos los usuarios DOTmed
Ética en DOTmed
Ver nuestro programa de ética
El oro parte programa del vendedor
Recibir las solicitudes de PH
Programa de distribuidor con servicio gold
Recibe solicitudes
Proveedores de atención de salud
Ver todos los HCP (abreviatura de asistencia médica) Herramientas
Trabajos/Entrenamiento
Encontrar/rellenar un trabajo
Parts Hunter +EasyPay
Obtener presupuestos para piezas
Certificado recientemente
Ver usuarios certificados recientemente
Recientemente clasificado
Ver usuarios certificados recientemente
Central de alquiler
Alquila equipos por menos
Vende equipos/piezas
Obtén más dinero
Mantenga el foro de los técnicos
Buscar ayuda y asesoramiento
Petición sencilla de propuestas
Obtén presupuestos para equipos
Feria comercial virtual
Encuentra servicio para el equipo
El acceso y el uso de este sitio está conforme a los términos y a las condiciones de nuestro AVISO LEGAL & AVISO DE LA AISLAMIENTO
Característica de y propietario DOTmeda .com, inc. Copyright ©2001-2017 DOTmed.com, Inc.
TODOS LOS DERECHOS RESERVADOS